$17.18
3.86% yesterday
Nasdaq, Dec 01, 10:00 pm CET
ISIN
US14167L1035
Symbol
CDNA

CareDx, Inc. Stock price

$17.18
+2.41 16.32% 1M
+0.10 0.59% 6M
-4.23 19.76% YTD
-8.46 33.00% 1Y
+4.00 30.35% 3Y
-41.81 70.87% 5Y
+10.65 163.09% 10Y
+8.13 89.83% 20Y
Nasdaq, Closing price Mon, Dec 01 2025
-0.69 3.86%
ISIN
US14167L1035
Symbol
CDNA
Industry

Key metrics

Basic
Market capitalization
$883.6m
Enterprise Value
$689.4m
Net debt
positive
Cash
$194.2m
Shares outstanding
51.4m
Valuation (TTM | estimate)
P/E
15.2 | 31.5
P/S
2.5 | 2.3
EV/Sales
1.9 | 1.8
EV/FCF
18.9
P/B
2.8
Financial Health
Equity Ratio
77.1%
Return on Equity
13.9%
ROCE
-11.0%
ROIC
-18.2%
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
$358.0m | $376.3m
EBITDA
$-34.1m | $30.3m
EBIT
$-36.6m | $9.3m
Net Income
$60.8m | $28.1m
Free Cash Flow
$36.4m
Growth (TTM | estimate)
Revenue
14.5% | 12.7%
EBITDA
38.9% | 159.2%
EBIT
37.2% | 117.3%
Net Income
142.3% | -46.6%
Free Cash Flow
2,861.0%
Margin (TTM | estimate)
Gross
67.6%
EBITDA
-9.5% | 8.1%
EBIT
-10.2%
Net
17.0% | 7.5%
Free Cash Flow
10.2%
More
EPS
$1.1
FCF per Share
$0.7
Short interest
13.9%
Employees
647
Rev per Employee
$520.0k
Show more

Is CareDx, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,070 stocks worldwide.

CareDx, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

15 Analysts have issued a CareDx, Inc. forecast:

10x Buy
67%
5x Hold
33%

Analyst Opinions

15 Analysts have issued a CareDx, Inc. forecast:

Buy
67%
Hold
33%

Financial data from CareDx, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '25
+/-
%
358 358
14% 14%
100%
- Direct Costs 116 116
8% 8%
32%
242 242
18% 18%
68%
- Selling and Administrative Expenses 208 208
11% 11%
58%
- Research and Development Expense 69 69
7% 7%
19%
-34 -34
39% 39%
-10%
- Depreciation and Amortization 2.56 2.56
1% 1%
1%
EBIT (Operating Income) EBIT -37 -37
37% 37%
-10%
Net Profit 61 61
142% 142%
17%

In millions USD.

Don't miss a Thing! We will send you all news about CareDx, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

CareDx, Inc. Stock News

Neutral
Business Wire
7 days ago
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA) – a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – today announced the publication of the third manuscript from Surveillance HeartCare Outcomes Registry (SHORE) in the Jou...
Neutral
Business Wire
22 days ago
BRISBANE, Calif.--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA)- The Transplant Company™ — a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers — today announced the company will participate in the following investor conferences: Stephens Investment Co...
Neutral
Business Wire
24 days ago
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA) — The Transplant Company™ — a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, today announced the award of inducement grants. On November 4, 2025, as an inducement material ...
More CareDx, Inc. News

Company Profile

CareDx, Inc. operates as a transplant diagnostics company,which discovers, develops, and commercializes diagnostic solutions. Its product includes AlloMap, AlloSure, and Laboratory products. The company was founded on December 21, 1998 and is headquartered in Brisbane, CA.

Head office United States
CEO John Hanna
Employees 647
Founded 1998
Website www.caredx.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today